BamSEC and AlphaSense Join Forces
Learn More

Allergan Finance LLC

Formerly NYSE: ACT

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.3
from 425 13 pages Dated May 19, 2013 Warner Chilcott PLC and Actavis, Inc. Expenses Reimbursement Agreement Contents
12/34/56
EX-2.3
from 8-K 13 pages Dated May 19, 2013 Warner Chilcott PLC and Actavis, Inc. Expenses Reimbursement Agreement Contents
12/34/56
EX-2.1
from 425 113 pages Dated May 19, 2013 Warner Chilcott PLC, Actavis, Inc., Actavis Limited Actavis Ireland Holding Limited, Actavis W.C. Holding LLC, and Actavis W.C. Holding 2 LLC Transaction Agreement Dublin Contents
12/34/56
EX-2.1
from 8-K 113 pages Dated May 19, 2013 Warner Chilcott PLC, Actavis, Inc., Actavis Limited Actavis Ireland Holding Limited, Actavis W.C. Holding LLC, and Actavis W.C. Holding 2 LLC Transaction Agreement Dublin Contents
12/34/56
EX-2.9B
from 10-K 4 pages State of Nevada Ross Miller Secretary of State Scott W. Anderson Deputy Secretary for Commercial Recordings Office of the Secretary of State Certified Copy February 12, 2013
12/34/56
EX-2.9A
from 10-K 9 pages State of Nevada Ross Miller Secretary of State Scott W. Anderson Deputy Secretary for Commercial Recordings Office of the Secretary of State Certified Copy January 17, 2013
12/34/56
EX-2.1
from 8-K 151 pages Share Purchase Agreement Between Stijn Van Rompay Pieter Van Rompay Leon Van Rompay Leon Van Rompay in His Capacity of the Managers of Uteron Pharma Invest Burgerlijke Maatschap François Fornieri Yima Sprl Jean-Michel Foidart Majocepi Sprl Stijn Van Rompay and François Fornieri in Their Capacity as Managers of Uteron Pharma Participations I Société Civile Others Named Herein as Sellers and Watson Pharma Actavis Sàrl as Purchaser and Watson Pharmaceuticals, Inc as the Purchaser Guarantor for the Sale and Purchase of 100% of the Outstanding Securities in Uteron Pharma SA Date: 19 January 2013 I
12/34/56
EX-2.1
from 8-K 50 pages Spa Deed of Modification and Withdrawal From Escrow Accounts
12/34/56
EX-2.1
from 8-K 215 pages 25 April 2012 Nitrogen Ds Limited Landsbanki Islands Hf. Almc Eignarhaldsfélag Ehf. Argon Management S.À R.L. (As Indirect Equity Holders) Deutsche Bank AG, London Branch Landsbanki Islands Hf. (As Debt Holders) the Managers Details of Whom Are Set Out in Part 2 of Schedule 1 (As Managers) Almc Hf. (As Almc Guarantor) Actavis Acquisition Debt S.À R.L. (As Vendor) Watson Pharma S.À R.L. (As Purchaser) and Watson Pharmaceuticals, Inc. (As Purchaser Guarantor) Sale and Purchase Agreement Related to Actavis Pharma Holding 4 Ehf., Actavis Inc. and Actavis S.À R.L. 99 Bishopsgate London Ec2m 3xf +44.20.7710.1000 (Tel) WWW.LW.com Contents
12/34/56
EX-2.1
from 8-K 80 pages Share Purchase Agreement
12/34/56
EX-2.1
from 8-K 43 pages Stock Purchase Agreement
12/34/56
EX-2.1
from 8-K 90 pages Purchase and Collaboration Agreement by and Among Columbia Laboratories, Inc., Coventry Acquisition, Inc. and Watson Pharmaceuticals, Inc. Dated as of March 3, 2010
12/34/56
EX-2.2
from 8-K 14 pages First Amendment to Share Purchase Agreement
12/34/56
EX-2.1
from 8-K 86 pages Share Purchase Agreement by and Among Robin Hood Holdings Limited, Watson Pharmaceuticals, Inc., Purchaser, the Sellers, and the Shareholders’ Representative Dated as of June 16, 2009
12/34/56
EX-2.2
from DEFA14A 4 pages Gentlemen: Reference Is Made to the Agreement and Plan of Merger (The “Agreement”) Dated as of March 12, 2006 by and Among Watson Pharmaceuticals, Inc., Water Delaware, Inc. and Andrx Corporation. Capitalized Terms Used and Not Defined Herein Shall Have the Meanings Given to Such Terms in the Agreement. Notwithstanding the Terms Set Forth in the Agreement, for Good and Valuable Consideration, the Receipt and Sufficiency of Which Are Hereby Acknowledged, the Parties Hereto Agree That: 1. Section 8.1(b) of the Agreement Is Hereby Amended to Read in Its Entirety as Follows
12/34/56
EX-2.2
from 8-K 4 pages Gentlemen: Reference Is Made to the Agreement and Plan of Merger (The “Agreement”) Dated as of March 12, 2006 by and Among Watson Pharmaceuticals, Inc., Water Delaware, Inc. and Andrx Corporation. Capitalized Terms Used and Not Defined Herein Shall Have the Meanings Given to Such Terms in the Agreement. Notwithstanding the Terms Set Forth in the Agreement, for Good and Valuable Consideration, the Receipt and Sufficiency of Which Are Hereby Acknowledged, the Parties Hereto Agree That: 1. Section 8.1(b) of the Agreement Is Hereby Amended to Read in Its Entirety as Follows
12/34/56
EX-2.1
from 8-K 57 pages Agreement and Plan of Merger by and Among Watson Pharmaceuticals, Inc., Water Delaware, Inc., Andrx Corporation, March 12, 2006 Agreement and Plan of Merger
12/34/56